DFFN - Diffusion Pharmaceuticals Inc. Stock Price, Fair Value and News

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

DFFN Price Action

DFFN RSI Chart

DFFN Valuation

Market Cap

28.6M

Price/Earnings (Trailing)

-2.4

Price/Sales (Trailing)

2.85

EV/EBITDA

-0.93

Price/Free Cashflow

-2.5

DFFN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

DFFN Fundamentals

DFFN Revenue

Revenue (TTM)

10.1M

DFFN Earnings

Earnings (TTM)

-11.9M

Earnings Growth (Yr)

-321.06%

Earnings Growth (Qtr)

-105.17%

DFFN Profitability

Operating Margin

100.00%

EBT Margin

-228.40%

Return on Equity

-26.18%

Return on Assets

-24.44%

Free Cashflow Yield

-40.03%

DFFN Investor Care

Shares Dilution (1Y)

45.45%

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	8.1M	9.7M	10.1M	0
2023	0	0	0	7.1M
2022	0	0	0	0
2021	0	0	0	0
2020	0	0	0	0
2019	0	0	0	0
2018	0	0	0	0
2017	0	0	2.9M	0
2014	1.5M	2.0M	2.4M	0
2013	1.6M	1.5M	1.3M	1.1M
2012	3.7M	3.6M	2.8M	1.8M
2011	0	2.2M	2.8M	3.3M
2010	0	0	0	1.7M

Get all data in R, Python etc through our Historical Stock Data APIs

About Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Inc. Frequently Asked Questions

What is the ticker symbol for Diffusion Pharmaceuticals Inc.? What does DFFN stand for in stocks?

DFFN is the stock ticker symbol of Diffusion Pharmaceuticals Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Diffusion Pharmaceuticals Inc. (DFFN)?

As of Thu Oct 31 2024, market cap of Diffusion Pharmaceuticals Inc. is 28.64 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DFFN stock?

You can check DFFN's fair value in chart for subscribers.

Is Diffusion Pharmaceuticals Inc. a good stock to buy?

The fair value guage provides a quick view whether DFFN is over valued or under valued. Whether Diffusion Pharmaceuticals Inc. is cheap or expensive depends on the assumptions which impact Diffusion Pharmaceuticals Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DFFN.

What is Diffusion Pharmaceuticals Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Oct 31 2024, DFFN's PE ratio (Price to Earnings) is -2.4 and Price to Sales (PS) ratio is 2.85. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DFFN PE ratio will change depending on the future growth rate expectations of investors.